One of my favorite reads of the year is from the Yale Investments Office, which manages their $25.6 billion endowment. You can find the report by clicking here. Yale is routinely the best-performing endowment in the world and has earned a remarkable 13.9 percent return over the last 30 years – well above the 10.7 percent return for US stocks, 8.7 percent return for foreign stocks and 7.1 percent return… Read More
Bond yields continued their downward march and fell to a five-week low yesterday as the yield on the 10-year US Treasury hit 1.73 percent. After starting the year at 2.24 percent, the benchmark yield dropped to 1.63 percent when the stock market bottomed out on February 11th and then climbed to 1.98 percent before falling again. As low as your yields are today, they are among the highest in the… Read More
Back in November, I wrote about the Sequoia fund (ticker symbol: SEQUX) on the losing side of a big bet on Valeant Pharmaceuticals (ticker symbol: VRX). Sequoia is a well-known fund, in part because when Warren Buffet unwound his hedge fund in the late 1960s, he recommended that his clients go to Sequoia, which was run by his friend Bill Ruane. Sequoia had good results and wasn’t afraid to take… Read More
I read a newsletter on and off that always features an obituary. I know a lot of people read them every day, but I find that a little depressing. I wrote about David Bowie’s passing back in January, and at the risk of writing too many obits, I thought I would note the death of John Gutfreund yesterday, who was dubbed the King of Wall Street by BusinessWeek magazine. Gutfreund… Read More
We have another special posting from Michael Lissner today, who will be writing Daily Insights more regularly. Also, there was a large typo yesterday, which said that we had traded $223.2 billion worth of stocks and ETFs. Far from it: we traded $223.2 million in stocks and ETFs, which is still a lot, but less than what I wrote, which makes more sense given our $1.2 billion in assets under management…. Read More
Some things are easy to measure, like the internal costs of a mutual fund or exchange traded fund (ETF) or how much we spend in commissions at our custodian to buy or sell stocks, bonds, mutual funds and ETFs. It’s much harder to measure the market impact of your trading, or how much you pay as a price-taker (like us) between the price to buy a security (the offer) and how… Read More
Barron’s cover article this weekend featured AQR, one of the fund companies that we use. You can find the article here, but a subscription is required. The article was great, really explaining the firm and many of their processes – so much so that one of the online commenters asked, ‘what is this, an ad?’ My only disappointment was that the article really highlighted their alternative mutual funds, strategies like managed futures… Read More
Value stocks are undoubtedly having a tough time these days. As I first wrote last November (click here for the article), value stocks are undergoing their worst period of underperformance since the tech bubble during the late 1990s. For the 10 years ending January 31st, the Russell 1000 Value index is up 7.03 percent compared to 7.92 percent for the Russell 1000 index of large cap stocks and 8.68 percent… Read More
I’ll bet that when you think of IPOs, or initial public offerings, you think of hot tech stocks like Facebook, Tesla or GoPro (granted, some of these stocks are a little less hot these days). I do too, so I was a little surprised to read in the Wall Street Journal that the biggest IPO this year is essentially a blank check for what is known as a Special Purpose… Read More
In the third quarter last year, I wrote at least two articles that used the acronym ZIRP, which stands for ‘zero interest rate policy.’ At the time, all of the conversation was about how the Fed was ending ZIRP with their first interest rate hike in seven years. Today is the two-month anniversary of the hike and the discussion has moved from ZIRP to NIRP, which stands for ‘negative interest… Read More
